Subtopic Deep Dive
mTOR in Autophagy and Metabolism
Research Guide
What is mTOR in Autophagy and Metabolism?
mTORC1 inhibits ULK1-dependent autophagy initiation while regulating lipid, nucleotide, and amino acid metabolism in cancer cells via nutrient-sensing Rag GTPases.
mTOR signaling integrates nutrient and growth factor signals to control cell growth, metabolism, and autophagy (Saxton and Sabatini, 2017; 7123 citations). In cancer, hyperactive mTORC1 suppresses autophagy and promotes anabolic metabolism, making it a key therapeutic target (Liu and Sabatini, 2020; 2577 citations). Over 20,000 papers cite mTOR's role in these processes since 2005.
Why It Matters
mTOR reprograms cancer cell metabolism toward glycolysis and biosynthesis, enabling rapid proliferation; rapalogs like everolimus induce autophagy and starve tumors by blocking this shift (Kim and Guan, 2015). In clinical trials, mTOR inhibitors combined with PI3K blockers improve outcomes in renal cell carcinoma by disrupting nutrient sensing via Rag GTPases (Porta et al., 2014). Liu and Sabatini (2020) highlight mTOR's nexus in ageing-related cancers, where metabolic dysregulation drives 30% of solid tumors.
Key Research Challenges
Rapalog Resistance Mechanisms
Cancer cells feedback-activate PI3K/AKT to bypass mTORC1 inhibition, reducing rapalog efficacy (Glaviano et al., 2023). Developing dual PI3K/mTOR inhibitors faces toxicity issues in trials (He et al., 2021). Over 1500 papers analyze these escapes since 2019.
Rag GTPase Nutrient Sensing
Rag GTPases variably sense amino acids across cancer types, complicating universal targeting (Saxton and Sabatini, 2017). Lysosomal mTORC1 localization disrupts autophagy feedback inconsistently (Settembre et al., 2012). Modeling these dynamics requires multi-omics integration.
Autophagy-Therapy Feedback
mTOR inhibition induces protective autophagy in tumors, countering therapeutic starvation (Kim and Guan, 2015). Balancing autophagy suppression with metabolic blockade remains unresolved (Laplante and Sabatini, 2009). Clinical data show variable TFEB activation responses.
Essential Papers
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton, David M. Sabatini · 2017 · Cell · 7.1K citations
mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu, David M. Sabatini · 2020 · Nature Reviews Molecular Cell Biology · 2.6K citations
mTOR signaling at a glance
Mathieu Laplante, David M. Sabatini · 2009 · Journal of Cell Science · 2.1K citations
The mammalian target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation and su...
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim, Kun‐Liang Guan · 2015 · Journal of Clinical Investigation · 2.0K citations
mTOR, a serine/threonine kinase, is a master regulator of cellular metabolism. mTOR regulates cell growth and proliferation in response to a wide range of cues, and its signaling pathway is deregul...
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Carmine Settembre, Roberto Zoncu, Diego L. Medina et al. · 2012 · The EMBO Journal · 1.9K citations
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam et al. · 2023 · Molecular Cancer · 1.6K citations
Abstract The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell cycle progression. Growth...
Targeting PI3K/Akt signal transduction for cancer therapy
Yan He, Miao Sun, Guo Geng Zhang et al. · 2021 · Signal Transduction and Targeted Therapy · 1.6K citations
Reading Guide
Foundational Papers
Start with Laplante and Sabatini (2009; 2102 citations) for mTOR basics, then Sarbassov et al. (2005; 1544 citations) for pathway growth roles, and Porta et al. (2014; 1437 citations) for cancer targeting.
Recent Advances
Liu and Sabatini (2020; 2577 citations) updates nutrition-ageing links; Glaviano et al. (2023; 1583 citations) covers PI3K/mTOR trials.
Core Methods
Core techniques include Rag GTPase pulldowns, TFEB luciferase reporters, and everolimus dose-response in metabolomics (Saxton and Sabatini, 2017; Settembre et al., 2012).
How PapersFlow Helps You Research mTOR in Autophagy and Metabolism
Discover & Search
Research Agent uses citationGraph on Saxton and Sabatini (2017) to map 7000+ citing papers linking mTOR to cancer metabolism, then exaSearch for 'mTORC1 ULK1 autophagy cancer' retrieves 500+ recent studies on rapalog effects.
Analyze & Verify
Analysis Agent runs readPaperContent on Liu and Sabatini (2020) to extract Rag GTPase models, verifies claims with CoVe against 10 similar papers, and uses runPythonAnalysis to plot glycolysis flux data from supplements with statistical GRADE scoring for therapeutic predictions.
Synthesize & Write
Synthesis Agent detects gaps in rapalog resistance via contradiction flagging across Glaviano et al. (2023) and He et al. (2021); Writing Agent applies latexSyncCitations and latexCompile to generate a review with exportMermaid diagrams of mTOR-autophagy networks.
Use Cases
"Analyze glycolysis changes in everolimus-treated cancer cells from paper supplements"
Research Agent → searchPapers('everolimus glycolysis mTOR') → Analysis Agent → runPythonAnalysis(pandas plot of flux data) → matplotlib graph with GRADE verification.
"Draft LaTeX figure of mTORC1-Rag-ULK1 pathway with citations"
Synthesis Agent → gap detection on Saxton 2017 → Writing Agent → latexGenerateFigure + latexSyncCitations (Kim 2015, Laplante 2009) → latexCompile PDF.
"Find GitHub code for mTOR metabolic modeling"
Research Agent → paperExtractUrls (Liu 2020) → Code Discovery → paperFindGithubRepo → githubRepoInspect (returns Python simulators for amino acid sensing).
Automated Workflows
Deep Research workflow scans 50+ mTOR cancer papers via citationGraph, structures a report on autophagy-metabolism links with DeepScan checkpoints verifying rapalog data (Glaviano 2023). Theorizer generates hypotheses on TFEB-mTOR feedback from Settembre et al. (2012), chaining exaSearch → runPythonAnalysis for simulation.
Frequently Asked Questions
What defines mTOR's role in autophagy?
mTORC1 phosphorylates ULK1 to block autophagy initiation under nutrient-rich conditions (Kim and Guan, 2015).
What are common methods to study mTOR metabolism?
Researchers use Rag GTPase mutants and everolimus in LC3 flux assays to measure autophagy and glycolysis shifts (Saxton and Sabatini, 2017).
What are key papers on mTOR in cancer?
Saxton and Sabatini (2017; 7123 citations) reviews growth-metabolism links; Glaviano et al. (2023; 1583 citations) details PI3K/mTOR therapies.
What open problems exist?
Overcoming feedback resistance to rapalogs and modeling lysosomal mTORC1 dynamics in heterogeneous tumors remain unsolved (Liu and Sabatini, 2020).
Research PI3K/AKT/mTOR signaling in cancer with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching mTOR in Autophagy and Metabolism with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers
Part of the PI3K/AKT/mTOR signaling in cancer Research Guide